Orchestra BioMed Holdings (OBIO) Minority Interest (2025 - 2026)
Orchestra BioMed Holdings (OBIO) posted quarterly Minority Interest of $9.8 million for Q1 2026, little changed quarter-over-quarter from $9.8 million in Q4 2025.
Powered by 
Analysis
Orchestra BioMed Holdings (OBIO) Minority Interest (2025 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has reported Minority Interest for 2 consecutive years, with $9.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Minority Interest changed N/A year-over-year to $9.8 million; the TTM figure through Mar 2026 stood at $9.8 million (changed N/A YoY), while the FY2025 annual figure was $9.8 million, changed N/A from the prior year.
- Minority Interest was little changed at $9.8 million in Q1 2026 per OBIO's latest filing, from $9.8 million in the prior quarter.
- Across five years, Minority Interest topped out at $9.8 million in Q4 2025 and bottomed at $9.8 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Orchestra BioMed Holdings | 322.25 Mn | 127.72 Mn | 63,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.10 Mn |
| Mar 31, 2026 | 9.77 Mn |
| Dec 31, 2025 | 9.81 Mn |